A randomised trial of custom-made compensators versus standard wedge compensators for breast radiotherapy

ISRCTN ISRCTN48733595
DOI https://doi.org/10.1186/ISRCTN48733595
Secondary identifying numbers Breast Dosimetry
Submission date
15/10/2002
Registration date
15/10/2002
Last edited
08/04/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

- - -
Scientific

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleA randomised trial of custom-made compensators versus standard wedge compensators for breast radiotherapy
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBreast cancer
Intervention1. Radiotherapy with either custom-made compensators
2. Standard wedge compensators
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/1997
Completion date19/01/2000

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexFemale
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Early breast cancer (T1-3a N0-1 M0)
2. Histological confirmation of invasive carcinoma
3. Breast-preserving surgery
4. Higher than average risk of radiation normal tissue changes due to large breast size or irregular breast shape
5. Radiotherapy to the breast +/- lymphatics
6. No previous malignancy
7. Written informed consent
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/1997
Date of final enrolment19/01/2000

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom

Sponsor information

Cancer Research UK (CRUK) (UK)
Charity

PO Box 123
Lincoln's Inn Fields
London
WC2A 3PX
United Kingdom

Phone +44 (0)207 317 5186
Email kate.law@cancer.org.uk
Website http://www.cancer.org.uk
ROR logo "ROR" https://ror.org/054225q67

Funders

Funder type

Research organisation

Cancer Research UK
Private sector organisation / Other non-profit organizations
Alternative name(s)
CR_UK, Cancer Research UK - London, CRUK
Location
United Kingdom
Institute of Cancer Research
Government organisation / National government
Alternative name(s)
Institute of Cancer Research - CIHR, CIHR Institute of Cancer Research, L'Institut du cancer, Institut du cancer, ICR - CIHR, ICR, IC
Location
Canada
Royal Marsden Hospital

No information available

South East Thames Regional Health Authority

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan